Gakken Science Books: The Story Behind the "World's First" Drug Expected to Extend Cats' Lives by Treating Kidney Disease – 'Research on AIM' Released
NQ Score
44/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Gakken, a group company of Gakken Holdings, has started pre-orders for 'Research on AIM: The Story Behind the "World's First" Drug Expected to Extend Cats' Lives,' a book that chronicles the research and development of a potential cat kidney disease treatment drug. Supervised by Toru Miyazaki, it is scheduled for release on June 4, 2026.